Alchemy Labs Inc.'s initial public offering prospectus dated June 25, 2026, has been filed with and accepted by the TSX Venture Exchange, and filed with and receipted by the Ontario Securities Commission on June 25, 2026.

The prospectus was also filed under Multilateral Instrument 11-102, Passport System, in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Prince Edward Island, Saskatchewan, and Yukon. A receipt for the prospectus is deemed to be issued by the regulator in each of those jurisdictions, if the conditions of the instrument have been satisfied.

The gross proceeds to be received by the company upon closing of the offering are a minimum of $10-million (10 million units at $1 per unit) and a maximum of $15-million (15 million units at $1 per unit).

The company is classified as an industrial, technology or life sciences company.

Commence date:  At the opening on July 9, 2026, the common shares will be listed and immediately halted on the TSX Venture Exchange.

Offering price:  $1

Corporate jurisdiction:  British Columbia

Capitalization:  unlimited common shares with no par value, of which 54,549,120 common shares issued and outstanding upon closing of the offering

Escrowed shares:  14,722,612 common shares subject to National Policy 46-201 escrow

Transfer agent:  Endeavor Trust Corp.

Trading symbol:  ALCH

Cusip No.:  01375A 10 2

Agent:  Haywood Securities Inc. (lead), ATB Capital Markets Corp., Beacon Securities Ltd., Canaccord Genuity Corp. and Ventum Financial Corp.

Agents' warrants:  533,617 non-transferable agents' compensation options (Each option entitles the holder to purchase one common share at $1 for up to 24 months from the closing of the offering.)

For further information, please refer to the company's prospectus dated June 25, 2026, available on SEDAR+.